Skip to content
JYMEDI
AVOTA Tab.

Medicine · Oral Medicine

AVOTA Tab.

Dutasteride + Tadalafil

  • Concurrent approach to coexisting symptoms
  • Improved patient compliance and convenience
  • Ideal for stable, long-term maintenance therapy
Inquire about this productDownload Catalog (PDF)

Specifications

Active ingredients
Dutasteride 0.5 mg and Tadalafil 5 mg fixed-dose combination
Dosage form
Tablet
Pack size
30 tablets
Indication
Treatment of symptoms associated with moderate to severe benign prostatic hyperplasia (BPH)
Dosage and administration
One tablet once daily, orally
Classification
Prescription drug

Certifications

  • Approved for export by the MFDS (Korea)

Product Details

Avota Tab. brochure

A product that combines the potent effects of dutasteride with tadalafil to alleviate patient concerns.

Dutasteride: Potent DHT Inhibition Mechanism

Reduction in prostate volume, suppression of hair loss progression.

  • Dutasteride 0.5mg potently inhibits DHT and minimizes its impact on hair follicles, contributing to the suppression of hair loss progression.
  • It inhibits both type 1 and type 2 5α-reductase, reducing DHT levels by over 90%.
    [Finasteride reduces DHT by approximately 70%]
  • Numerous clinical studies have confirmed the efficacy of dutasteride in suppressing the progression of hair loss.
Tadalafil: Improvement of Erectile Dysfunction
  • Tadalafil 5mg selectively inhibits the PDE5 enzyme.
  • This leads to an increase in cyclic guanosine monophosphate (cGMP) levels, resulting in smooth muscle relaxation.
  • Consequently, blood flow to the corpus cavernosum increases, and improvement in erectile function is expected.
  • The low-dose, 5mg once-daily therapy has demonstrated sustained efficacy and excellent tolerability in multiple randomized controlled trials.
  • Its safety in long-term administration has also been established, and sustained blood flow improvement is expected with continuous administration for 6 months or longer.
Active Ingredients Dutasteride 0.5mg and Tadalafil 5mg fixed-dose combination
Benefits Indicated for the treatment of symptoms associated with moderate to severe benign prostatic hyperplasia (BPH) with a once-daily oral administration of one tablet.

Related Products

UROGUARD Tab.

Medicine · Oral Medicine

UROGUARD Tab.

Dutasteride + Tadalafil

TERGASE Inj.

Medicine · Injection

TERGASE Inj.

Extremely high purity(99%) Hyaluronidase